Viewing Study NCT04302103


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-25 @ 5:04 PM
Study NCT ID: NCT04302103
Status: COMPLETED
Last Update Posted: 2023-10-11
First Post: 2020-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor)-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module